Condition: Parkinson Disease · REM Sleep Behavior Disorder · Dementia, Lewy Body · Sponsor: Insel Gruppe AG, University Hospital Bern
The study aims to systematically document the course of REM sleep behavior disorder (RBD) and investigate possible clinical and imaging biomarkers for disease progression and conversion risk to Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The study will use artificial intelligence to analyze imaging and develop a reliable method to predict and stratify patients approaching conversion to overt a-synucleinopathy. Participants will be clinically evaluated and 2 imaging procedures will be done.
This description comes directly from the study's public registry record.
Axel Rominger, Prof. Dr. med. · +41 316322610 · axel.rominger@insel.ch
Franziska Strunz, PhD · +41 316643022 · studies.nuk@insel.ch
Always discuss trial participation with your own doctor first.
| Inselspital, University Clinic for Nuclear Medicine | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06629207